Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
More opportunities elsewhere
Oh , I agree they've been misleading. Don't get me wrong I am miffed. I've lost money on a falsely reported agenda. I've got a third of holdings left.
But, lets see if they show more veracity from now on. One more BS event and I'll be out.
It’s not how many I sold Tech. It’s that I believed the previous RNS releases suggesting that the “ next steps are to finalise standard production and operating protocols and to commence clinical trials that should lead to an accredited Laboratory Developed (LDT) test for launch initially in the USA” When clearly they’ve been spinning plates
Nope, I agree, I've no idea how many you sold OAPK, but you did keep referencing it (derisking). . So therefore its fair game to mention..
And since you have become more vociferous since, then it's a fair assumption that the two are linked.
Cause and effect whichever way it is
You’ve no idea how many I sold or still hold Tech.
I might be “bloody minded” but I’m not trying to defend the indefensible nor am I making deliberately overly positive assumptions about what the placing funds will or will not be spent on, which could mislead.
Oops , ignore last paragraph artefact
I do try to be fair; there is no such thing as a neutral stance in life though.
And the same way that I sometimes think that Neil probably engages in some subconscious confirmation and Jace definitely got carried away with potential...
I also think that now you've sold many, you're taking an opposite stance to be bloody minded (I know you can be a tad anyway ;o) that's OK with me)
But..your question..
"What’s that got to do with signing an agreement for 15% Royalties with CorePath and now 10% with BIO. A company set up by Mr Behnke in February this year" ?
C'mon OAPk, as Neil said, there's more companies now under one umbrella.. it's more streamlined but there's a cost for that streamlining.
The other stuff about unprofessional directors talk and fundraise... Well I can't argue with that the fundraise was inopportune. It's hard to know the reasons behind canceling the previous funding deal.
And those " interviews" on stockbox and directors talk, etc all..
None of them involving any company or what I would call interrogative challenging interviews
They're all just a PR exercise to an extent
at’s that got to do with signing an agreement for 15% Royalties with CorePath and now 10% with BIO. A company set up by Mr Behnke in February this year ?
RE "Neil, why was BIO needed...."
Dead simple - in the same way that my customers structure a deal with my company. They don't want the hassle of going to supplier A for this part, supplier B for this part, supplier C for the design, supplier D for testing.
What’s that got to do with signing an agreement for 15% Royalties with CorePath and now 10% with BIO. A company set up by Mr Behnke in February this year ?
Do you think if E3 Fund were happy to provide the £500k drawdown there would have been a placing? Do you think the interview posted 16 minutes after the release of the Placing RNS was the behaviour of a Professional and reputable company? Do you think the interview was Professional ? Do you think the interviewer was professional in their preparation and questions they asked?
Is that the sort of way you would conduct yourself in your business ?
Evening Techtonic.
The reference to AXBD was a response to Bufflehead's earlier post.
Oakp20
Can you explain how i can possibly be pumping a share when i have repeatedly said i am here long term and not interested
in the day to day share price?
In the same spirit as your request to Techtonic to provide a link, can you also provide the link to support your claim that "amateur placing forced on them because the agreed finance with e3 fund wasn't forthcoming!?
Re the placing: we will know for sure in 7 days if the placing completed. On that basis, can you tell us where YOU think the funds will be used?
Re the company being Bill Benke's house, so what? Look at Companies House to see how many companies registered office is a private residence, or a single office in a complex, or even just a PO box. It is simply a requirement where legal documents can be served.
Re the HNW's: Do you not believe the bod have performed their due diligence into whether they are legit?
Allan's comment -"absolutely delighted to have FINALLY got this agreement together, something we have been negotiating for a while"
RE "Neil, why was BIO needed...."
Dead simple - in the same way that my customers structure a deal with my company. They don't want the hassle of going to supplier A for this part, supplier B for this part, supplier C for the design, supplier D for testing.
In return for me bringing all these steps in-house, and them being provided with a "one stop shop" i am rewarded with bigger orders .
In CIZ's case, they have amalgamated these steps into one company.
We get a smaller royalty percentage initially, but are rewarded by the sales these combined partners will generate.
This is enhanced by a free holding in BIO company and a share in their profits.
Hope this helps
Neil
I don’t think I missed the AGM notice, but I am guessing June time again? I am planning on attending work permitting.
On Corepath Vs BIO.
My take is that Corepath are still responsible for the testing etc etc. But they was never paying for it. An accredited lab is needed as part of the process to test the entire spectrum of kit needed that will make up the approved FDA marked test.
BIO are paying for the facilitation of this and then marketing it.
The two trades must have been a transfer of some sort. They had no impact in either direction.
AS has not found a US Co to partner with, on acceptable terms to what he proposed. Hence Bill was clever enough to see the opportunity to try and set up a US Co and discuss the opportunity with his so called sophisticated HNWI, who he is asking to fund the next stages of developing the lab devloped test for US market. Fair enough Bill. Wise man.
What I find incredible is AS responding to a question about a test for UK market with the first country mentioned being China.
How can two £52K trades today go through at 1.80p when I could not even sell £10K the whole day.
Must be brokers, or else they were buys. But I tried a £7K buy after and Barclays would not allow it.
I predict that AS will avoid Investor Meet platform in future. He cannot avoid AGM. So I will be attending, as I hope you can Neil. We want the same outcome. An approved test ASAP
Tech think Widdy needed the rest
Bloviate - good word that
I don't know if you realise OAPk that you derided Widglide so much, you've turned into him by association! ;o)
I'm still retaining a healthy skepticism here. They do talk a good game. We'll see.
Need to get this to market and stop all the bloviating.
Semantics OAPK. It's part of a bigger group whichever label you want to put on it.
But different from your comment Tech
OAPK..Directors talk 6 min 26 sec.
"We're incorporating our existing deal that we have with core path laboratories, and rolling it altogether, and in the end we will end up with a net 10% royalty".
They're in there as part of the deal
I have only ever found Neil’s posts to be informative and helpful, always with the message to DYOR. Please carry on the good work Neil
Tech
“But Corepath is PART of BIO”
Please can you post the link to this information to confirm that.
Cheers
Ps Neil..
I take it your mention of Abingdon Health was just a shot in the dark?
OAPK .
But Corepath is PART of BIO...
So Corepath is still at the centre of this
So now The consortium for funding is bigger, hence Ciz % has gone down a tad Imo.
I do agree with Neil more on this part with Bill Behnke - it was always the intention he was to lead the way in the US. Just that we got carried away with Biotechne potential.
On a personal note I am cheesed off with ordering of those RNS..it does snack of some incompetence, but it could be mates getting in or simply bad timing with the BB deal.
Cost me the amount I was going to pay for an operation for a friend though.
RNS Number : 5257K - 06 May 2022 - Heads of terms signed with CorePath Laboratories, USA,
"CorePath is a specialist oncology reference laboratory bringing together leading clinicians, scientists, academic affiliates and state of the art facilities and will be responsible for all activities in the USA including development, clinical trials and test validation for clinical use"
RNS Number : 8949I - 02 April 2024 - Licensing and Partnership MoU for North America
"BIO intends to fully fund all expenditure on development, clinical trials, accreditation and marketing of diagnostic tests for the CIZ1B Biomarker in North America which would represent a significant saving on current planned expenditure by the Company"
""No thanks from Corepath? I don't understand that statement. Neil"
Neil can you explain why you think BIO was needed given the Heads of Terms with CorePath which clearly states as above
CorePath "will be responsible for all activities in the USA including development, clinical trials and test validation for clinical use" ?
Why was there a need for Mr Behnke set up BIO and why have CIZ signed the MoU for annual royalty fees of 10% of net sales instead of the "Proposed 15% royalty and royalty sharing arrangements for the Company over all offering of products and services using CIZ1B via CorePath in the USA" ?
neil you are relentless.
they haven't even announced they've got the optimised mabs let alone a working high throughput ciz1b blood test for lung cancer and your pumping out this "the fact we don't need it now to fund the clinical trials means it will all be put to further work, re the development of other cancer detection."
unbelievable like that pathetic ************* attempt at pumping the share price to let the placees exit.
amateur placing forced on them because the agreed finance with e3 fund wasn't forthcoming. seriously underestimated pi holdings and completely taken pi's for granted and treated them in a disgusting manner.
bio was set up by mr behnke at his house with a doctor also involved. trying to make it out as anything else is derisory and misleading.
key word dependent - "bio's ability to meet its financial obligations is dependant on a group of sophisticated high net worth investors in the usa."
how big is the group of sophisticated hnwi's ? will they be impressed enough to part with their cash and invest in bio. currently a company set up at his home address with a doctor friend on the board.
keep pumping. be lucky.